Filing Details
- Accession Number:
- 0001553878-14-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-27 16:47:04
- Reporting Period:
- 2014-06-25
- Filing Date:
- 2014-06-27
- Accepted Time:
- 2014-06-27 16:47:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1180432 | John Maraganore | C/O Alnylam Pharmaceuticals, Inc. 300 Third Street Cambridge MA 02142 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-25 | 56,834 | $7.47 | 163,154 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-25 | 23,988 | $65.86 | 139,166 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-25 | 32,846 | $66.29 | 106,320 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-06-26 | 56,834 | $7.47 | 163,154 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-26 | 49,464 | $64.66 | 113,690 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-26 | 5,570 | $65.50 | 108,120 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-26 | 1,800 | $66.61 | 106,320 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-06-25 | 56,834 | $0.00 | 56,834 | $7.47 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-06-26 | 56,834 | $0.00 | 56,834 | $7.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 170,502 | 2005-10-12 | 2014-12-21 | No | 4 | M | Direct |
| 113,668 | 2005-10-12 | 2014-12-21 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,654 | Indirect | By Managed Account |
Footnotes
- The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. The options exercised and sold by the reporting person were due to expire on December 21, 2014.
- Sale prices ranged from $65.09 to $66.08.
- Sale prices ranged from $66.09 to $66.83.
- Sale prices ranged from $64.11 to $65.07.
- Sale prices ranged from $65.11 to $66.10.
- Sale prices ranged from $66.20 to $67.02.
- The reporting person owns 2,654 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
Billionaire Hedge Funds
